News

Abbott signals high single-digit sales growth outlook, eyes biosimilars launch and pipeline momentum amid $1B diagnostics headwinds
Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline ...